Grantham, Mayo, Van Otterloo & Co (GMO)
EXAS

Grantham, Mayo, Van Otterloo & Co (GMO)’s Exact Sciences EXAS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-217,755
Closed -$22.1M – 663
2025
Q4 		$22.1M Buy
+217,755
New +$17.5M 0.06% 161

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s EXAS Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 217,755 shares — an estimated $22.1M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $22.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 217,755 Exact Sciences shares in Q1 2026, an estimated $22.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Exact Sciences position peaked at $22.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.